Portfolio Co Investors 2026 for Morningside Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Morningside Ventures accounts for 22 tracked companies with verified cap-table data, 22 of which disclose round sizes totalling $2.2B. The median disclosed raise is $93M, and the largest is Gracell Biotechnologies at $520M, ahead of New Amsterdam Pharma ($196M) and Amylyx Pharmaceuticals ($172M).
The names that recur most often on these co-invested cap tables are Morningside Ventures (22 companies), Vivo Capital (2 companies), OrbiMed (2 companies), Lilly Asia Ventures (2 companies), Janus Henderson Investors (2 companies), Forbion (2 companies). By latest disclosed round, the market skews Series C (10), Series A (4), Series B (4), IPO (1).
Companies tracked: 22
Disclosed funding total: $2.2B across 22 companies
Median disclosed raise: $93M
Largest raise: Gracell Biotechnologies — $520M
Stage mix: Series C 10 · Series A 4 · Series B 4 · IPO 1
